Header Logo

Connection

Mark Klempner to Drug Evaluation

Back to Details
This is a "connection" page, showing publications Mark Klempner has written about Drug Evaluation.
Mark Klempner
Connection Strength
0.006
Drug Evaluation
  1. Mier JW, Vachino G, Klempner MS, Aronson FR, Noring R, Smith S, Brandon EP, Laird W, Atkins MB. Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects. Blood. 1990 Nov 15; 76(10):1933-40.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.